Genetics of caffeine and brain-related outcomes - a systematic review of observational studies and randomized trials
- PMID: 37029915
- DOI: 10.1093/nutrit/nuad029
Genetics of caffeine and brain-related outcomes - a systematic review of observational studies and randomized trials
Abstract
Context: Although the stimulant and anxiogenic properties of caffeine are widely accepted, research on its specific effects on the brain remains controversial. Growing evidence shows that interindividual differences in caffeine response may be partly due to variations in genes such as CYP1A2 and ADORA2A, which have been used to identify individuals as "fast" or "slow" caffeine metabolizers and as having a "high" or "low" caffeine sensitivity, respectively.
Objective: The objective of this review was to identify, evaluate, and discuss current evidence on the associations between common genetic variants, caffeine consumption, and brain-related outcomes in humans.
Data sources: PubMed and Embase databases were searched for relevant reports based on a predetermined search strategy.
Data extraction: Reports of observational and experimental studies on healthy adults who underwent (a) genetic analysis for polymorphisms in genes associated with caffeine metabolism and effects and (b) measurements of brain-related effects such as anxiety, insomnia, and cognitive performance associated with the consumption of caffeine (habitual intake or supplementation) were included.
Data analysis: Of the 22 records included, 15 were randomized controlled trials, 6 were cross-sectional studies, and 1 was a genome-wide association study. The main outcomes identified were cognitive performance (n = 9), anxiety (n = 7), and sleep disturbance/insomnia (n = 6). Polymorphisms in the CYP1A2 gene were associated with cognitive function, while variations in the ADORA2A gene were associated with anxiety and sleep disturbance.
Conclusion: The present review has provided evidence that variability in the CYP1A2 and the ADORA2A genes may modulate the association between caffeine and brain-related outcomes. Future studies are warranted to investigate the specific polymorphisms implicated in each brain outcome, which cognitive functions are particularly related to caffeine (simple vs complex), whether there are gender differences in anxiety effects, and how habitual caffeine intake may influence the acute effects of caffeine.
Systematic review registration: PROSPERO registration no. CRD42021257556.
Keywords: anxiety; brain-related effects; caffeine; coffee; cognition; genetics; sleep.
© The Author(s) 2023. Published by Oxford University Press on behalf of the International Life Sciences Institute. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Similar articles
-
Effects of CYP1A2 and ADORA2A Genotypes on the Ergogenic Response to Caffeine in Professional Handball Players.Genes (Basel). 2020 Aug 13;11(8):933. doi: 10.3390/genes11080933. Genes (Basel). 2020. PMID: 32823594 Free PMC article.
-
Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.Eur J Neurol. 2011 May;18(5):756-65. doi: 10.1111/j.1468-1331.2011.03353.x. Epub 2011 Jan 31. Eur J Neurol. 2011. PMID: 21281405 Free PMC article.
-
Impact of Genetic Variability on Physiological Responses to Caffeine in Humans: A Systematic Review.Nutrients. 2018 Sep 25;10(10):1373. doi: 10.3390/nu10101373. Nutrients. 2018. PMID: 30257492 Free PMC article.
-
CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study.Int J Obes (Lond). 2022 Jan;46(1):162-168. doi: 10.1038/s41366-021-00972-6. Epub 2021 Sep 25. Int J Obes (Lond). 2022. PMID: 34564706 Clinical Trial.
-
Genetics of caffeine consumption and responses to caffeine.Psychopharmacology (Berl). 2010 Aug;211(3):245-57. doi: 10.1007/s00213-010-1900-1. Epub 2010 Jun 9. Psychopharmacology (Berl). 2010. PMID: 20532872 Free PMC article. Review.
Cited by
-
Caffeine: A Neuroprotectant and Neurotoxin in Traumatic Brain Injury (TBI).Nutrients. 2025 Jun 4;17(11):1925. doi: 10.3390/nu17111925. Nutrients. 2025. PMID: 40507194 Free PMC article. Review.
-
Bioactive Compounds for Customized Brain Health: What Are We and Where Should We Be Heading?Int J Environ Res Public Health. 2023 Aug 3;20(15):6518. doi: 10.3390/ijerph20156518. Int J Environ Res Public Health. 2023. PMID: 37569058 Free PMC article. Review.
-
Habitual coffee consumption and risk of dementia in older persons: modulation by CYP1A2 polymorphism.Eur J Epidemiol. 2024 Jan;39(1):81-86. doi: 10.1007/s10654-023-01060-x. Epub 2023 Oct 31. Eur J Epidemiol. 2024. PMID: 37906419
-
Personalizing Dietary Polyphenols for Health Maintenance and Disease Management: A Nutrigenetic Approach.Curr Nutr Rep. 2025 Feb 5;14(1):29. doi: 10.1007/s13668-025-00620-9. Curr Nutr Rep. 2025. PMID: 39907890 Review.
-
Longitudinal Effects of Lifetime Caffeine Consumption on Levels of Depression, Anxiety, and Stress: A Comprehensive Review.Curr Nutr Rep. 2025 Feb 1;14(1):26. doi: 10.1007/s13668-025-00616-5. Curr Nutr Rep. 2025. PMID: 39890748 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical